Innate Pharma S.A.
IPHA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$49 | -$8 | -$58 | -$53 |
| Dep. & Amort. | $2 | $5 | $45 | $5 |
| Deferred Tax | $0 | $0 | $0 | -$2 |
| Stock-Based Comp. | $4 | $4 | $4 | $3 |
| Change in WC | $39 | -$32 | -$13 | -$10 |
| Other Non-Cash | -$3 | -$2 | $2 | -$1 |
| Operating Cash Flow | -$7 | -$33 | -$19 | -$58 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $10 | $23 | $3 | $0 |
| Other Inv. Act. | $0 | -$2 | -$0 | $0 |
| Investing Cash Flow | $9 | $21 | $2 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$9 | -$2 | -$2 | $27 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | $0 | $0 | $0 |
| Financing Cash Flow | -$6 | -$2 | -$2 | $27 |
| Forex Effect | -$1 | $0 | -$0 | -$0 |
| Net Chg. in Cash | -$4 | -$14 | -$20 | -$33 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $71 | $84 | $104 | $137 |
| End Cash | $66 | $71 | $84 | $104 |
| Free Cash Flow | -$7 | -$35 | -$20 | -$60 |